Step 1: Integrase is an HIV enzyme that catalyses insertion of the reverse-transcribed viral DNA into the host cell genome. Integrase strand transfer inhibitors (INSTIs) block this step.
Step 2: Raltegravir was the first integrase inhibitor approved (2007) for HIV treatment. The drug name suffix -gravir identifies the integrase inhibitor class (e.g., raltegravir, dolutegravir, elvitegravir, bictegravir).
Step 3: The remaining options are protease inhibitors, recognisable by the -navir suffix: Indinavir, Lopinavir and Tipranavir all block the HIV protease enzyme that cleaves polyprotein precursors during viral maturation, not integrase.
Conclusion: The correct answer is Raltegravir, matching the printed key.